Elevance Health Inc (ELV) - CarelonRx Revenue (DISCONTINUED) (I:EHIELVCR)
Level Chart
Basic Info
|
Elevance Health Inc (ELV) - CarelonRx Revenue is at a current level of 0.000, unchanged from 0.000 last quarter and down from 7.249B one year ago. This is a change of N/A from last quarter and -100.0% from one year ago. |
| Report | Fiscal.ai |
| Category | Segments & KPIs |
| Region | United States |
| Source | Fiscal.ai |
|
Data provided via Fiscal.ai |
Stats
| Last Value | 0.00 |
| Latest Period | Sep 2023 |
| Last Updated | Nov 6 2023, 15:11 EST |
| Average Growth Rate | -0.38% |
| Value from Last Quarter | 0.00 |
| Change from Last Quarter | N/A |
| Value from 1 Year Ago | 7.249B |
| Change from 1 Year Ago | -100.0% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |
Historical Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 7.523B |
| September 30, 2022 | 7.249B |
| June 30, 2022 | 7.071B |
| March 31, 2022 | 6.683B |
| December 31, 2021 | 6.801B |
| Date | Value |
|---|---|
| September 30, 2021 | 6.549B |
| June 30, 2021 | 6.219B |
| March 31, 2021 | 5.862B |
| December 31, 2020 | 5.863B |
| September 30, 2020 | 5.582B |
| June 30, 2020 | 5.269B |
| March 31, 2020 | 5.197B |
| December 31, 2019 | 3.232B |
News
Headline
Time (ET)
Basic Info
|
Elevance Health Inc (ELV) - CarelonRx Revenue is at a current level of 0.000, unchanged from 0.000 last quarter and down from 7.249B one year ago. This is a change of N/A from last quarter and -100.0% from one year ago. |
| Report | Fiscal.ai |
| Category | Segments & KPIs |
| Region | United States |
| Source | Fiscal.ai |
|
Data provided via Fiscal.ai |
Stats
| Last Value | 0.00 |
| Latest Period | Sep 2023 |
| Last Updated | Nov 6 2023, 15:11 EST |
| Average Growth Rate | -0.38% |
| Value from Last Quarter | 0.00 |
| Change from Last Quarter | N/A |
| Value from 1 Year Ago | 7.249B |
| Change from 1 Year Ago | -100.0% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |